Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q416463> ?p ?o }
Showing triples 1 to 71 of
71
with 100 triples per page.
- Q416463 subject Q7486806.
- Q416463 subject Q8210727.
- Q416463 subject Q8533683.
- Q416463 subject Q8808739.
- Q416463 abstract "Alosetron (original brand name: Lotronex LOW-trah-nex; originator: GSK) is a 5-HT3 antagonist used for the management of severe diarrhea-predominant irritable bowel syndrome (IBS) in women only. It is currently marketed by Prometheus Laboratories Inc. (San Diego). Alosetron was withdrawn from the market in 2000 owing to the occurrence of serious life-threatening gastrointestinal adverse effects, but was reintroduced in 2002 with availability and use restricted.".
- Q416463 atcPrefix "A03".
- Q416463 atcSuffix "AE01".
- Q416463 bioavailability "50.0".
- Q416463 casNumber "122852-42-0".
- Q416463 chEBI "253342".
- Q416463 drugbank "DB00969".
- Q416463 fdaUniiCode "13Z9HTH115".
- Q416463 iupacName "5-methyl-2-[(4-methyl-1H-imidazol-5-yl)methyl]-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol-1-one".
- Q416463 pubchem "2099".
- Q416463 thumbnail Alosetron.svg?width=300.
- Q416463 wikiPageWikiLink Q1066061.
- Q416463 wikiPageWikiLink Q1472.
- Q416463 wikiPageWikiLink Q1477.
- Q416463 wikiPageWikiLink Q1477327.
- Q416463 wikiPageWikiLink Q14864419.
- Q416463 wikiPageWikiLink Q14890102.
- Q416463 wikiPageWikiLink Q14916181.
- Q416463 wikiPageWikiLink Q1532338.
- Q416463 wikiPageWikiLink Q16552.
- Q416463 wikiPageWikiLink Q178436.
- Q416463 wikiPageWikiLink Q188151.
- Q416463 wikiPageWikiLink Q204711.
- Q416463 wikiPageWikiLink Q206077.
- Q416463 wikiPageWikiLink Q212322.
- Q416463 wikiPageWikiLink Q221463.
- Q416463 wikiPageWikiLink Q2343082.
- Q416463 wikiPageWikiLink Q238521.
- Q416463 wikiPageWikiLink Q2408462.
- Q416463 wikiPageWikiLink Q3430882.
- Q416463 wikiPageWikiLink Q377978.
- Q416463 wikiPageWikiLink Q4.
- Q416463 wikiPageWikiLink Q409236.
- Q416463 wikiPageWikiLink Q410011.
- Q416463 wikiPageWikiLink Q431289.
- Q416463 wikiPageWikiLink Q458.
- Q416463 wikiPageWikiLink Q5059596.
- Q416463 wikiPageWikiLink Q546003.
- Q416463 wikiPageWikiLink Q586582.
- Q416463 wikiPageWikiLink Q588321.
- Q416463 wikiPageWikiLink Q589298.
- Q416463 wikiPageWikiLink Q6431240.
- Q416463 wikiPageWikiLink Q7234359.
- Q416463 wikiPageWikiLink Q7486806.
- Q416463 wikiPageWikiLink Q8210727.
- Q416463 wikiPageWikiLink Q838966.
- Q416463 wikiPageWikiLink Q8533683.
- Q416463 wikiPageWikiLink Q8808739.
- Q416463 wikiPageWikiLink Q939416.
- Q416463 wikiPageWikiLink Q99.
- Q416463 atcPrefix "A03".
- Q416463 atcSuffix "AE01".
- Q416463 bioavailability "50".
- Q416463 casNumber "122852".
- Q416463 chebi "253342".
- Q416463 drugbank "DB00969".
- Q416463 iupacName "5".
- Q416463 pubchem "2099".
- Q416463 unii "13".
- Q416463 type ChemicalSubstance.
- Q416463 type Drug.
- Q416463 type ChemicalObject.
- Q416463 type Thing.
- Q416463 type Q8386.
- Q416463 comment "Alosetron (original brand name: Lotronex LOW-trah-nex; originator: GSK) is a 5-HT3 antagonist used for the management of severe diarrhea-predominant irritable bowel syndrome (IBS) in women only. It is currently marketed by Prometheus Laboratories Inc. (San Diego). Alosetron was withdrawn from the market in 2000 owing to the occurrence of serious life-threatening gastrointestinal adverse effects, but was reintroduced in 2002 with availability and use restricted.".
- Q416463 label "Alosetron".
- Q416463 depiction Alosetron.svg.